The largest database of trusted experimental protocols

Nephelostar nephelometer

Manufactured by BMG Labtech
Sourced in Germany

The NEPHELOstar is a nephelometer instrument designed for measuring light scattering in liquid samples. It is used to quantify the concentration of particles or molecules in a solution.

Automatically generated - may contain errors

7 protocols using nephelostar nephelometer

1

Serum Biomarkers in Dialysis Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sera from both the HD and HDF patients were drawn before and after dialysis during all in centre dialysis sessions in one week. Sera were analysed for Ca, magnesium, albumin, P, bicarbonate and CRP on a routine automated analyser (Cobas c502 immunochemistry analyser (Roche Diagnostics, Almere, The Netherlands). For the analysis of fetuin-A and the CPP transformation time (T50) an additional 5ml, non-additive BD-vacutainer glass serum tube was collected. Within 240 minutes after collection these samples were centrifuged at room temperature (20°C) for 15 minutes. Of this 800 ul of serum was stored at 4°C and send to the lab of Calciscon AG in Bern, Switzerland, where they were analysed within 72 hours after collection.
The serum fetuin-A concentration was measured by nephelometry, a test first established by the Jahnen-Dechent group [28 (link)]. T50 was determined by the method described by Pasch et al. [13 (link)]. Samples were supersaturated by adding Ca (10mM) and P (6mM) to initiate the formation of primary CPP. The time of spontaneous transformation to secondary CPPs was measured by a nephelostar nephelometer (BMG Labtech, Ortenberg, Germany).
Correction for hemoconcentration for fetuin-A was performed by the method of Bergstrom et al. [29 (link)]: uncorrected post dialysis fetuin-A (g/L)/(1+ (Δ body weight (kg)/0.2*post dialysis body weight (kg)).
+ Open protocol
+ Expand
2

Calcification Propensity Test Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
T 50 -time was determined by Calciscon AG, Bern, Switzerland as described previously [15] . In brief, the calcification propensity test is an in vitro nano-particle assay, which measures the time of conversion of primary to secondary CPPs. Serum samples were supersaturated with calcium and phosphate to increase their final concentrations by 10 and 6 mM, respectively. Secondary CPP formation time (T 50 -time) was measured by a nephelostar nephelometer (BMG Labtech, Ortenberg, Germany). Other parameters were measured as detailed in Gaggl et al. [25] .
The
+ Open protocol
+ Expand
3

Solubility Determination of Compound 45 and Carnosine

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 4

The solubility of Compound 45 and carnosine in physiologic buffer (phosphate buffered saline, pH 7.4; PBS) were determined using a BMG Labtech NEPHELOstar nephelometer (Offenburg, Germany) with Galaxy analytical software, version 4.32R2. Stock solutions of each compound were prepared initially in dimethyl sulfoxide (DMSO); Compound 45 was soluble at a concentration of 50 mM in DMSO, while carnosine was not. Subsequently, dilution series of both compounds were prepared directly in PBS (pH 7.4) for evaluation of solubility using nephlometry, with a top concentration of 500 mg/mL for each compound and serial 1:2 dilutions. A positive control compound was included to qualitatively illustrate concentration-solubility relationships using heat maps. Compound 45 was soluble in physiologic buffer at a concentration of 500 mg/mL, while carnosine was soluble only at concentrations of 250 mg/mL.

+ Open protocol
+ Expand
4

Measuring Serum Biomarkers in Mineralization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum T50 was measured by Calciscon AG, Biel, Switzerland, as previously described using a Nephelostar nephelometer (BMG Labtech, Ortenberg, Germany)40 (link). The mean interassay CVA for T50 was 3.4%. CPP-II hydrodynamic radius was measured by dynamic light scattering using a DynaPro Plate Reader II (Wyatt Technology, Santa Barbara, CA, USA) as described by Chen et al.47 (link) The interassay CVA for CPP-II size was 4%. Commercial immunoassays were used to measure iFGF23 (Kainos Laboratories, Tokyo, Japan), 1,25 dihydroxyvitamin D Immunodiagnostic Systems, Boldon, UK), and fetuin-A (R&D Systems, Minneapolis, USA) according to the manufacturer’s instructions. Mean interassay CVA were 3.8%, 5.5%, and 3.2%, respectively. Serum citrate was measured using a colorimetric assay (Sigma-Aldrich, Darmstadt, Germany) with a mean interassay CVA of 3.5%.
+ Open protocol
+ Expand
5

Vorin-cat Expression in E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
E. coli BL21(DE3) cells were transformed with 100 ng of the appropriate expression vector or combination of vectors by heat shock method, and a single colony was used to inoculate a 5 mL LB culture containing either 30 µg/mL kanamycin or 30 µg/mL kanamycin and 100 µg/mL streptomycin. The 5 mL cultures were incubated at 37 °C for 6 h with shaking. Culture OD600 readings were taken after 18 h, and the values were used to dilute each culture to OD600 = 2 × 10−4 in sterile 1.5 mL tubes with fresh LB containing the appropriate antibiotic. Expression of Vorin-cat and VorinI was induced by addition of IPTG to a final concentration of 0.1 mM. Each control or experimental culture was dispensed into a 96-well plate in 200 µL aliquots. Plates were incubated at 35°C with shaking using a NEPHELOstar nephelometer (BMG LABTECH) and culture turbidity was measured in nephelometric turbidity units (NTU) every 5 min for 16.5 h. The BacLight Live/Dead bacterial viability kit (L-7012, Molecular Probes) was used to assess cell viability after a three-hour induction of vorin-cat in E. coli Lemo21 cells.
+ Open protocol
+ Expand
6

Nephelometric Turbidity Measurement Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Solubility measurement samples were prepared in a 96-well Corning Costar plate with a total sample volume of 200 µL in either PBS buffer with 1% DMSO (v/v) or pure water. A BMG Labtech NEPHELOstar nephelometer was used to measure turbidity of the samples with the following parameters per the instrument manufacturer: Gain = 80, Laser Focus= 2.50 mm, and Laser Intensity = 90%. Samples were shaken in the nephelometer by orbital shaking for 3 s prior to the turbidity measurement. Sample values were blanked in the instrument software using the corresponding PBS and DMSO condition values. Turbidity 4000 NTU Calibration Standard Formazin (Millipore-Sigma) was used as a positive control for all turbidity measurements. The turbidity of each sample was measured within 20 min of initial preparation.
+ Open protocol
+ Expand
7

Serum T50 Calcification Propensity Measurement

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum samples for T50 measurement were obtained from the participants through venipuncture at the same moment when blood sampling for routine blood chemistry and PPi was performed. Serum samples were stored at −80 °C without thawing. T50 calcification propensity measurements were performed at Calciscon AG, Nidau, Switzerland, as previously described [10 (link)]. In short, serum samples were thawed, vortexed and centrifuged after which they were supersaturated with calcium and phosphate solutions (pH 7.40). Pipetting was performed using an automated high-precision pipetting system (Freedom EVO 100, Tecan, Switzerland). Samples were then measured in triplicate in 96-well plates at 37 °C for 600 min in a Nephelostar nephelometer (BMG Labtech, Ortenberg, Germany), hence, live-monitoring the transformation of primary to secondary CPPs in the different samples (batch 1: n = 23; batch 2: n = 34). To determine the half-maximal transformation time (T50), data analyses of nonlinear regression curves were performed using the Calciscon T50 Analysis Software. Intra- and interassay coefficients of variation were 2.2% and 3.4%, respectively.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!